Primary Objectives:~• To assess the safety and tolerability of single ascending oral doses of ABP-671 in Healthy Volunteers (HVs).~Secondary Objectives:~• To characterize the pharmacokinetics (PK) and pharmacodynamics (PD) profiles of single ascending oral doses of ABP-671 in HVs.
The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of ABP-671 administered orally in healthy volunteers.